Patents by Inventor Michele MIOZZI

Michele MIOZZI has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Crystalline microparticles of a beta-agonist coated with a fatty acid
    Patent number: 10993916
    Abstract: Crystalline microparticles consisting of a phenylalkylamino beta2-adrenergic agonist coated with a C12-C20 fatty acid are useful for the preparation of pharmaceutical aerosol formulations in form of suspension in a liquefied propellant gas or powder formulations.
    Type: Grant
    Filed: May 12, 2016
    Date of Patent: May 4, 2021
    Assignee: Chiesi Farmaceutici S.p.A.
    Inventors: Gaetano Brambilla, Paolo Colombo, Francesca Buttini, Michele Miozzi
  • CRYSTALLINE MICROPARTICLES OF A BETA-AGONIST COATED WITH A FATTY ACID
    Publication number: 20200138724
    Abstract: Crystalline microparticles consisting of a phenylalkylamino beta2-adrenergic agonist coated with a C12-C20 fatty acid are useful for the preparation of pharmaceutical aerosol formulations in form of suspension in a liquefied propellant gas or powder formulations.
    Type: Application
    Filed: January 9, 2020
    Publication date: May 7, 2020
    Applicant: Chiesi Farmaceutici S.p.A.
    Inventors: Gaetano BRAMBILLA, Paolo Colombo, Francesca Buttini, Michele Miozzi
  • Preparation of micronized particles of an antimuscarinic compound by hydrodynamic cavitation
    Patent number: 9925168
    Abstract: Crystalline micronized particulate of a glycopyrronium salt may be prepared by hydrodynamic cavitation. The resulting drug particles are physically stable with regard to agglomeration and/or aggregation on storage.
    Type: Grant
    Filed: January 19, 2017
    Date of Patent: March 27, 2018
    Assignee: CHIESI FARMACEUTICI S.p.A.
    Inventors: Stephen P. Davanzo, Barry E. Nall, Timothy J. Rouse, Michele Miozzi
  • PREPARATION OF MICRONIZED PARTICLES OF AN ANTIMUSCARINIC COMPOUND BY HYDRODYNAMIC CAVITATION
    Publication number: 20170209414
    Abstract: Crystalline micronized particulate of a glycopyrronium salt may be prepared by hydrodynamic cavitation. The resulting drug particles are physically stable with regard to agglomeration and/or aggregation on storage.
    Type: Application
    Filed: January 19, 2017
    Publication date: July 27, 2017
    Applicant: CHIESI FARMACEUTICI S.P.A.
    Inventors: Stephen P. DAVANZO, Barry E. NALL, Timothy J. ROUSE, Michele MIOZZI
  • Inhalation particles comprising a combination of an anticholinergic, a corticosteroid and a beta-adrenergic
    Patent number: 9554992
    Abstract: Microparticles comprising a combination of an anticholinergic, a beta2-adrenoceptor agonist, and an inhaled corticosteroid are useful for the prevention and/or treatment of respiratory diseases.
    Type: Grant
    Filed: May 28, 2015
    Date of Patent: January 31, 2017
    Assignee: CHIESI FARMACEUTICI S.p.A.
    Inventors: Gaetano Brambilla, Michele Miozzi, Timothy J Rouse
  • CRYSTALLINE MICROPARTICLES OF A BETA-AGONIST COATED WITH A FATTY ACID
    Publication number: 20160324792
    Abstract: Crystalline microparticles consisting of a phenylalkylamino beta2-adrenergic agonist coated with a C12-C20 fatty acid are useful for the preparation of pharmaceutical aerosol formulations in form of suspension in a liquefied propellant gas or powder formulations.
    Type: Application
    Filed: May 12, 2016
    Publication date: November 10, 2016
    Applicant: Chiesi Farmaceutici S.p.A.
    Inventors: Gaetano Brambilla, Paolo Colombo, Francesca Buttini, Michele Miozzi
  • INHALATION PARTICLES COMPRISING A COMBINATION OF AN ANTICHOLINERGIC, A CORTICOSTEROID AND A BETA-ADRENERGIC
    Publication number: 20150352127
    Abstract: Microparticles comprising a combination of an anticholinergic, a beta2-adrenoceptor agonist, and an inhaled corticosteroid are useful for the prevention and/or treatment of respiratory diseases.
    Type: Application
    Filed: May 28, 2015
    Publication date: December 10, 2015
    Applicant: CHIESI FARMACEUTICI S.P.A.
    Inventors: Gaetano BRAMBILLA, Michele MIOZZI, Timothy J. ROUSE